
Global Radiopharmaceuticals for Diagnosis Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Radiopharmaceuticals for Diagnosis market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals for Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals for Diagnosis.
The Radiopharmaceuticals for Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopharmaceuticals for Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Radiopharmaceuticals for Diagnosis Segment by Company
Atom High-tech Co., Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
Tianjin Said Biopharmaceutical Co., Ltd.
Shenzhen Larven Bioengineering Technology Co., Ltd.
Shanghai Atom Kexing Pharmaceutical Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
Guangdong Xi'ai Pharmaceutical Co., Ltd.
Chengdu Zhonghe Gaotong Isotope Co., Ltd.
Chengdu Yunke Pharmaceutical Co., Ltd.
Chengdu Xinke Pharmaceutical Co., Ltd.
Beijing Zhibo High-tech Biotechnology Co., Ltd.
RadioMedix, Inc.
PDRadiopharma Inc.
Lantheus
Jubilant Radiopharma
GE Healthcare Ltd
DOE IP
Radiopharmaceuticals for Diagnosis Segment by Type
Strontium [89Sr] Chloride
Sodium Iodide [131I]
Iodine [125I] Sealed Seed Source
Technetium [99mTc] Pentetate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Dithiodithiocarbamate
Other
Radiopharmaceuticals for Diagnosis Segment by Application
Hospital
Clinic
Other
Radiopharmaceuticals for Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Radiopharmaceuticals for Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Radiopharmaceuticals for Diagnosis market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals for Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals for Diagnosis.
The Radiopharmaceuticals for Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopharmaceuticals for Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Radiopharmaceuticals for Diagnosis Segment by Company
Atom High-tech Co., Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
Tianjin Said Biopharmaceutical Co., Ltd.
Shenzhen Larven Bioengineering Technology Co., Ltd.
Shanghai Atom Kexing Pharmaceutical Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
Guangdong Xi'ai Pharmaceutical Co., Ltd.
Chengdu Zhonghe Gaotong Isotope Co., Ltd.
Chengdu Yunke Pharmaceutical Co., Ltd.
Chengdu Xinke Pharmaceutical Co., Ltd.
Beijing Zhibo High-tech Biotechnology Co., Ltd.
RadioMedix, Inc.
PDRadiopharma Inc.
Lantheus
Jubilant Radiopharma
GE Healthcare Ltd
DOE IP
Radiopharmaceuticals for Diagnosis Segment by Type
Strontium [89Sr] Chloride
Sodium Iodide [131I]
Iodine [125I] Sealed Seed Source
Technetium [99mTc] Pentetate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Dithiodithiocarbamate
Other
Radiopharmaceuticals for Diagnosis Segment by Application
Hospital
Clinic
Other
Radiopharmaceuticals for Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Radiopharmaceuticals for Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
116 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Radiopharmaceuticals for Diagnosis Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts (2020-2031)
- 1.3 Radiopharmaceuticals for Diagnosis Market by Type
- 1.3.1 Strontium [89Sr] Chloride
- 1.3.2 Sodium Iodide [131I]
- 1.3.3 Iodine [125I] Sealed Seed Source
- 1.3.4 Technetium [99mTc] Pentetate
- 1.3.5 Technetium [99mTc] Polymerized Albumin
- 1.3.6 Technetium [99mTc] Dithiodithiocarbamate
- 1.3.7 Other
- 1.4 Global Radiopharmaceuticals for Diagnosis Market Size by Type
- 1.4.1 Global Radiopharmaceuticals for Diagnosis Market Size Overview by Type (2020-2031)
- 1.4.2 Global Radiopharmaceuticals for Diagnosis Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Radiopharmaceuticals for Diagnosis Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Radiopharmaceuticals for Diagnosis Industry Trends
- 2.2 Radiopharmaceuticals for Diagnosis Industry Drivers
- 2.3 Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges
- 2.4 Radiopharmaceuticals for Diagnosis Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Radiopharmaceuticals for Diagnosis Revenue (2020-2025)
- 3.2 Global Top Players by Radiopharmaceuticals for Diagnosis Sales (2020-2025)
- 3.3 Global Top Players by Radiopharmaceuticals for Diagnosis Price (2020-2025)
- 3.4 Global Radiopharmaceuticals for Diagnosis Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Radiopharmaceuticals for Diagnosis Major Company Production Sites & Headquarters
- 3.6 Global Radiopharmaceuticals for Diagnosis Company, Product Type & Application
- 3.7 Global Radiopharmaceuticals for Diagnosis Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Radiopharmaceuticals for Diagnosis Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Radiopharmaceuticals for Diagnosis Players Market Share by Revenue in 2024
- 3.8.3 2023 Radiopharmaceuticals for Diagnosis Tier 1, Tier 2, and Tier 3
- 4 Radiopharmaceuticals for Diagnosis Regional Status and Outlook
- 4.1 Global Radiopharmaceuticals for Diagnosis Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Radiopharmaceuticals for Diagnosis Historic Market Size by Region
- 4.2.1 Global Radiopharmaceuticals for Diagnosis Sales in Volume by Region (2020-2025)
- 4.2.2 Global Radiopharmaceuticals for Diagnosis Sales in Value by Region (2020-2025)
- 4.2.3 Global Radiopharmaceuticals for Diagnosis Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Radiopharmaceuticals for Diagnosis Forecasted Market Size by Region
- 4.3.1 Global Radiopharmaceuticals for Diagnosis Sales in Volume by Region (2026-2031)
- 4.3.2 Global Radiopharmaceuticals for Diagnosis Sales in Value by Region (2026-2031)
- 4.3.3 Global Radiopharmaceuticals for Diagnosis Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Radiopharmaceuticals for Diagnosis by Application
- 5.1 Radiopharmaceuticals for Diagnosis Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Radiopharmaceuticals for Diagnosis Market Size by Application
- 5.2.1 Global Radiopharmaceuticals for Diagnosis Market Size Overview by Application (2020-2031)
- 5.2.2 Global Radiopharmaceuticals for Diagnosis Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Radiopharmaceuticals for Diagnosis Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Atom High-tech Co., Ltd.
- 6.1.1 Atom High-tech Co., Ltd. Comapny Information
- 6.1.2 Atom High-tech Co., Ltd. Business Overview
- 6.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.1.5 Atom High-tech Co., Ltd. Recent Developments
- 6.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
- 6.2.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Comapny Information
- 6.2.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
- 6.2.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.2.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
- 6.3 Tianjin Said Biopharmaceutical Co., Ltd.
- 6.3.1 Tianjin Said Biopharmaceutical Co., Ltd. Comapny Information
- 6.3.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
- 6.3.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.3.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
- 6.4 Shenzhen Larven Bioengineering Technology Co., Ltd.
- 6.4.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Comapny Information
- 6.4.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
- 6.4.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.4.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
- 6.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
- 6.5.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Comapny Information
- 6.5.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
- 6.5.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.5.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
- 6.6 Shanghai Xinke Pharmaceutical Co., Ltd.
- 6.6.1 Shanghai Xinke Pharmaceutical Co., Ltd. Comapny Information
- 6.6.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
- 6.6.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.6.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
- 6.7 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
- 6.7.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Comapny Information
- 6.7.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
- 6.7.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.7.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
- 6.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
- 6.8.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Comapny Information
- 6.8.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
- 6.8.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.8.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.8.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
- 6.9 Guangdong Xi'ai Pharmaceutical Co., Ltd.
- 6.9.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Comapny Information
- 6.9.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
- 6.9.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.9.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.9.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
- 6.10 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
- 6.10.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Comapny Information
- 6.10.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
- 6.10.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.10.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.10.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
- 6.11 Chengdu Yunke Pharmaceutical Co., Ltd.
- 6.11.1 Chengdu Yunke Pharmaceutical Co., Ltd. Comapny Information
- 6.11.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
- 6.11.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.11.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.11.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
- 6.12 Chengdu Xinke Pharmaceutical Co., Ltd.
- 6.12.1 Chengdu Xinke Pharmaceutical Co., Ltd. Comapny Information
- 6.12.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
- 6.12.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.12.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.12.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
- 6.13 Beijing Zhibo High-tech Biotechnology Co., Ltd.
- 6.13.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Comapny Information
- 6.13.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
- 6.13.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.13.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.13.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
- 6.14 RadioMedix, Inc.
- 6.14.1 RadioMedix, Inc. Comapny Information
- 6.14.2 RadioMedix, Inc. Business Overview
- 6.14.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.14.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.14.5 RadioMedix, Inc. Recent Developments
- 6.15 PDRadiopharma Inc.
- 6.15.1 PDRadiopharma Inc. Comapny Information
- 6.15.2 PDRadiopharma Inc. Business Overview
- 6.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.15.5 PDRadiopharma Inc. Recent Developments
- 6.16 Lantheus
- 6.16.1 Lantheus Comapny Information
- 6.16.2 Lantheus Business Overview
- 6.16.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.16.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.16.5 Lantheus Recent Developments
- 6.17 Jubilant Radiopharma
- 6.17.1 Jubilant Radiopharma Comapny Information
- 6.17.2 Jubilant Radiopharma Business Overview
- 6.17.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.17.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.17.5 Jubilant Radiopharma Recent Developments
- 6.18 GE Healthcare Ltd
- 6.18.1 GE Healthcare Ltd Comapny Information
- 6.18.2 GE Healthcare Ltd Business Overview
- 6.18.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.18.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.18.5 GE Healthcare Ltd Recent Developments
- 6.19 DOE IP
- 6.19.1 DOE IP Comapny Information
- 6.19.2 DOE IP Business Overview
- 6.19.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2020-2025)
- 6.19.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
- 6.19.5 DOE IP Recent Developments
- 7 North America by Country
- 7.1 North America Radiopharmaceuticals for Diagnosis Sales by Country
- 7.1.1 North America Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025)
- 7.1.3 North America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2031)
- 7.2 North America Radiopharmaceuticals for Diagnosis Market Size by Country
- 7.2.1 North America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025)
- 7.2.3 North America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Radiopharmaceuticals for Diagnosis Sales by Country
- 8.1.1 Europe Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025)
- 8.1.3 Europe Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2031)
- 8.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
- 8.2.1 Europe Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025)
- 8.2.3 Europe Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Country
- 9.1.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Country
- 9.2.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Radiopharmaceuticals for Diagnosis Sales by Country
- 10.1.1 South America Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025)
- 10.1.3 South America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2031)
- 10.2 South America Radiopharmaceuticals for Diagnosis Market Size by Country
- 10.2.1 South America Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025)
- 10.2.3 South America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country
- 11.1.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country
- 11.2.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Radiopharmaceuticals for Diagnosis Value Chain Analysis
- 12.1.1 Radiopharmaceuticals for Diagnosis Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Radiopharmaceuticals for Diagnosis Production Mode & Process
- 12.2 Radiopharmaceuticals for Diagnosis Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Radiopharmaceuticals for Diagnosis Distributors
- 12.2.3 Radiopharmaceuticals for Diagnosis Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.